This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The NIH Pragmatic Trials Collaboratory will hold a virtual workshop on February 5 and 6, 2025, on Digging Into Dilemmas of Pragmatic Clinical Trials. A keynote presentation will address the state of healthcare delivery in the United States and the constraints on healthcare systems that are important for researchers to understand. Day 1 of the workshop will develop participants understanding of the landscape for pragmatic research, including stressors on the healthcare system and barriers and opp
The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as potent in early testing as the company expected.
Many current trends in clinical research will likely continue regardless of the upcoming changes in the White House. The need to incorporate technology into our clinical trials processes, alongside a continued emphasis on the power of artificial intelligence ( AI) , will remain a priority for both the U.S. Food and Drug Administration (FDA) and the rest of government in 2025.
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with menopause as well as a common breast cancer therapy.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind Biosciences, led by an oral therapy ready for Phase 2 testing.
Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging artificial intelligence, according to Silicon Valley Bank.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
This is the latest episode of the free DDW narrated podcast, titled Where are the global breakthroughs, opportunities and developments in cancer research?, which covers three articles written for DDW Volume 24 Issue 2, Spring 2023 of DDW. They are called: Global breakthroughs in cancer drug discovery , The Achilles heel of cancer , and Immunotherapy is here to stay .
In this episode, Ayesha spoke with Judy Chou, PhD, CEO, President and Board member of AltruBio , a company developing first-in-class immunomodulators to target diseases of the immune system. AltruBios pipeline includes compounds being investigated for indications such as ulcerative colitis, psoriatic arthritis and acute graft vs. host disease. Prior to joining AltruBio, Dr.
Clinical trial ancillary equipment and supplies encompass an astonishing variety of products and categories. This includes everything one might need to conduct a clinical trial, from IV bags to centrifuges, blood pressure monitors to syringes, refrigerators, and everything in between. The list is extensive, and… The post Addressing the Complexities of Clinical Trial Ancillary Equipment and Supplies appeared first on Imperial Clinical Research Services Blog.
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an oversubscribed Series A financing round of $411m.
Table of Contents Sr# Headings 1 Introduction: Navigating the Pharma Marketing Network 2 Building a Strong Pharma Marketing Network 3 Strategies for Digital Success in Pharma Marketing 4 Leveraging Data and Partnerships for Impact Introduction: Navigating the Pharma Marketing Network The Pharma Marketing Network is more than just a collection of professionalsits a dynamic ecosystem where strategy, creativity, and innovation converge.
Table of Contents Sr# Headings 1 Introduction: Why Staying Updated on Pharma News Matters 2 Emerging Trends in Pharma Marketing 3 The Role of Technology in Modern Pharma Strategies 4 Adapting to Regulatory Changes and Compliance Introduction: Why Staying Updated on Pharma News Matters In the fast-paced pharmaceutical industry, information is power. For marketing teams, staying ahead of the curve with the latest Pharma News can mean the difference between a campaign that thrives and one that fall
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Table of Contents Sr# Headings 1 Introduction: The Evolution of Pharmaceutical Marketing 2 Patient-Centric Marketing: Putting Patients First 3 Digital Transformation in Pharma Marketing 4 Building Trust Through Data and Compliance Introduction: The Evolution of Pharmaceutical Marketing In todays fast-paced world, pharmaceutical marketing is no longer about just promoting productsits about connecting, educating, and empowering.
MaaT Pharma is focused on developing microbiome-related therapies and its lead candidate is MaaT013, a treatment for acute graft-versus-host disease (aGvHD) with gastrointestinal involvement.
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
167 
Let's personalize your content